[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100472017":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":51,"collaborators":53,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":19,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":19,"overallStatus":37,"whyStopped":19,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Karolinska Institutet","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Patients with MINOCA undergoing CMR","Patients will be their own controls",[12],"Diagnostic Test: Cardiac magnetic resonance imaging to study coronary microvascular dysfunction",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Cardiac magnetic resonance imaging to study coronary microvascular dysfunction","Myocardial perfusion mapping will be investigated after administration of adenosine",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Per Tornvall, MD","Karolinska Instítutet","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","+468616100","per.tornvall@ki.se",{"name":31,"role":27,"phone":32,"phoneExt":19,"email":33},"Peder Sörensson, MD","+46812370000","perder.sorensson@regionstockholm.se",[35],{"facility":36,"status":37,"city":38,"state":19,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Per Tornvall","RECRUITING","Stockholm","11551","Sweden","SE",{"type":43,"coordinates":44},"Point",[45,46],18.06871,59.32938,{"lat":46,"lon":45},[49],{"name":36,"role":27,"phone":50,"phoneExt":19,"email":29},"+46722180560",{"type":24,"investigatorFullName":36,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Professor",[54],{"name":55,"class":56},"Region Stockholm","OTHER_GOV","100472017","stockholm-myocardial-infarction-with-nonobstructive-coronaries-study-3-100472017",false,"NCT05426408","Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3","Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3 - Pilot Study of Prevalence of Coronary Microvascular Dysfunction in Myocardial Infarction with Nonobstructive Coronary Arteries","SMINC-3","Inclusion Criteria:\n\n* a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%\n* age 35-80 years\n* reading and writing proficiency in Swedish\n\nExclusion Criteria:\n\n* Claustrofobia\n* Arrythmia and\u002For pacemaker (atrial fibrillation and AV-block I- III)\n* Asthma or severe chronic obstructive lung disease\n* eGFR \\\u003C 30 ml\u002Fmin\n* spontaneous coronary artery dissection\n* acute pulmonary embolism\n* acute myocardial infarction type 2\n* cardiomyopathy other than takotsubo syndrome\n* a previous myocardial infarction due to CAD","ALL","35 Years","79 Years",{"count":69,"type":70},85,"ESTIMATED","INTERVENTIONAL",[73],"NA","The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.",[76],"Myocardial Infarction with Nonobstructive Coronary Arteries","2025-03-06",{"date":79,"type":80},"2025-03-10","ACTUAL",{"date":82,"type":80},"2022-11-01",{"date":84,"type":70},"2026-06-30",{"name":5,"class":6},1]